NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
NAMSW - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.16B
Close$
$3.02
67.5% downside
Current Fair Value
67.5% downsideOvervalued by 67.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.16 Billion |
|---|---|
| Enterprise Value | $738.36 Million |
| Earnings per Share | $-1.75 |
| Beta | 0.11 |
| Outstanding Shares | 124,136,610 |
Return
| Return on Equity | -32.48% |
|---|---|
| Return on Assets | -29.78% |
| Return on Invested Capital | -32.58% |
Valuation & Multiples
| P/E Ratio | -11.78 |
|---|---|
| PEG | 15.53 |
| Price to Sales | - |
| Price to Book Ratio | 1.86 |
| Enterprise Value to Revenue | 28.47 |
| Enterprise Value to EBIT | -3.59 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 11, 2026
EPS Estimate
-$0.49
Consensus analyst estimateRevenue Estimate
$7.54 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 3, 2027
EPS Estimate
-$0.46
Consensus analyst estimateRevenue Estimate
$13.98 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.